|
Course Information
|
Back to Catalog
|
This lesson is supported by:
|
By
Robert G. Wahler, PharmD, CGP, FASCP
Clinical Assistant Professor
University at Buffalo
School of Pharmacy
Director, Clinical Pharmacy Services
Niagara Hospice
Faculty Disclosure
Robert G. Wahler discloses no significant financial conflicts of interest
Goals and Objectives
At the conclusion of this knowledge-based activity, participants will be able to:
1. Describe the most recent actions taken by the Food and Drug Administration (FDA) on marketed, unapproved narcotics and list the products most impacted.
2. Identify equivalent dosages for the most commonly used and interchanged narcotics.
3. Compare and contrast various narcotic and formulation choices for specific clinical situations based on primary literature evidence and clinician experience.
4. Discuss patient safety concerns and medication errors potentiated by therapeutic substitutions.
|
|
|
|
|
|
ASCP Member Price: $25
Non-Member Price: $45
|
|
ACPE - Pharmacists Accreditation
|
|
ASCP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This home study web activity has been assigned a maximum of 1 credit hours and the ACPE UPN: 203-000-09-054-H01-P.
Expiration Date: 06/16/2012
|
| |
To receive educational credit, participants must complete an online evaluation form and pass the online assessment with a score of 70% or better. If you do not receive a minimum score of 70% or better, you are permitted 4 retake(s). After passing the assessment, you can view, print and track your statements of credit online.
|
|
|
The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|
This lesson is supported by:
|
|
|
